Beta Bionics reported cash from operations of -$14.62M and free cash flow of -$15.66M for the quarter ended Jun 2026, down 7.6% year over year. This cash flow statement covers 11 quarters of results from Dec 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Net Income | -8.31M | -10.79M | -10.15M | -12.09M | -16.21M | -16.87M | -14.21M | -13.47M | -21.89M | -23.40M | |
| Share-based CompensationStock Comp. | 5.20M | 1.36M | 1.50M | 1.98M | 1.55M | 8.22M | 7.23M | 6.77M | 4.30M | 6.97M | 7.02M |
| Gains from Investment SecuritiesGains Investment | 4.14M | 3.67M | -0.42M | 6.02M | 12.45M | ||||||
| Asset Writedowns and ImpairmentWritedown | 0.02M | 0.03M | 0.03M | 0.02M | 0.02M | ||||||
| Cash from OperationsCash from Ops. | -12.14M | -12.24M | -9.61M | -14.28M | -19.98M | -13.59M | -8.73M | -8.63M | -23.83M | -14.62M | |
| Depreciation, Depletion & Amortization | |||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.28M | 0.28M | 0.28M | 0.30M | -0.92M | -0.81M | 2.63M | 0.40M | 0.40M | 0.41M | |
| Change in Working Capital | |||||||||||
| Change in ReceivablesChange Receivables | 1.92M | 2.64M | -1.50M | 4.56M | -2.94M | 2.33M | 0.17M | 5.59M | -1.37M | 2.32M | |
| Change in InventoryChange Inventory | 2.41M | 3.89M | 3.93M | 1.21M | 2.62M | 1.73M | 3.33M | 2.20M | 1.80M | 0.21M | |
| Change in Account PayablesChange Payables | 0.41M | 1.06M | 0.11M | -0.06M | -0.10M | 0.57M | 1.10M | 0.53M | -3.33M | 2.86M | |
| Change in Accured ExpensesChange Accured Exp. | -0.23M | 2.30M | 1.20M | 3.57M | -5.27M | 2.72M | 4.12M | 5.86M | -5.22M | -0.22M | |
| Investing Activities | |||||||||||
| Capital ExpendituresCapex | 0.41M | 0.55M | 1.88M | 0.56M | 0.33M | 1.78M | 1.28M | 1.90M | 1.38M | 1.04M | |
| Sales of Property, Plant and EquipmentPP&E (Sale) | 0.05M | ||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 8.00M | 24.00M | 24.00M | 16.00M | 28.00M | 23.00M | 71.00M | 48.00M | 48.00M | 48.00M | |
| Cash from Investing ActivitiesCash from Investing | 7.64M | 3.30M | 15.24M | -29.66M | -179.12M | 6.17M | 9.49M | 0.66M | 21.84M | 26.93M | |
| Financing Activities | |||||||||||
| Other financing activitiesOther financing | 0.01M | 0.01M | 0.04M | 0.04M | 15.59M | 0.62M | 1.80M | ||||
| Cash from Financing ActivitiesCash from Financing | 0.01M | -0.11M | -1.18M | 56.89M | 211.12M | 0.04M | 2.65M | 1.06M | 0.62M | 1.80M | |
| Change in Capital Stock | |||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 0.94M | 2.62M | 1.73M | 0.71M | |||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 195.43M | -0.90M | |||||||||
| Additional items | |||||||||||
| Change in Cash | -4.49M | -9.04M | 4.45M | 12.95M | 12.02M | -7.38M | 3.41M | -6.91M | -1.37M | 14.11M | |
| Free Cash FlowFCF | -12.55M | -12.79M | -11.49M | -14.84M | -20.31M | -15.37M | -10.01M | -10.53M | -25.21M | -15.66M | |
| Net Cash FlowNCF | -4.49M | -9.04M | 4.45M | 12.95M | 12.02M | -7.38M | 3.41M | -6.91M | -1.37M | 14.11M |